Vivelle-Dot
- Product NDC
- 66758-148
- Requested package NDC
- 66758-148-83
- 11-digit product format
- 667580148
- Labeler code
- 66758
- Product ID
- 66758-148_8e8ae172-5a0d-4888-a825-0c6cfa1afac9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- estradiol
- Dosage form
- PATCH, EXTENDED RELEASE
- Route
- TRANSDERMAL
- Labeler
- Sandoz Inc
- Application
- NDA020538
- Marketing category
- NDA
- Marketing start
- 1999-01-08
- Substance
- ESTRADIOL
- Active strength
- .075 mg/d
- Pharmacologic classes
- Estradiol Congeners [CS], Estrogen Receptor Agonists [MoA], Estrogen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020538-005 | VIVELLE-DOT | ESTRADIOL | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 |
| N020538-006 | VIVELLE-DOT | ESTRADIOL | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 |
| N020538-007 | VIVELLE-DOT | ESTRADIOL | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 |
| N020538-008 | VIVELLE-DOT | ESTRADIOL | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 |
| N020538-009 | VIVELLE-DOT | ESTRADIOL | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020538-005 | AB1 |
| N020538-006 | AB1 |
| N020538-007 | AB1 |
| N020538-008 | AB1 |
| N020538-009 | AB1 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-005 | VIVELLE-DOT | 0.0375MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-006 | VIVELLE-DOT | 0.05MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-007 | VIVELLE-DOT | 0.075MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-008 | VIVELLE-DOT | 0.1MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD, RS | 1999-01-08 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-009 | VIVELLE-DOT | 0.025MG/24HR | SYSTEM / TRANSDERMAL | AB1 | RLD | 2002-05-03 | b8a1b40f171c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N020538-005 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-006 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-007 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-008 | AB1 | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | N020538-009 | AB1 | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-005 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-006 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-007 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-008 | AB1 | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | N020538-009 | AB1 | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-005 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-006 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-007 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-008 | AB1 | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | N020538-009 | AB1 | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-005 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-006 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-007 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-008 | AB1 | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020538-009 | AB1 | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-005 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-006 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-007 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-008 | AB1 | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020538-009 | AB1 | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-005 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-006 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-007 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-008 | AB1 | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020538-009 | AB1 | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-005 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-006 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-007 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-008 | AB1 | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020538-009 | AB1 | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-005 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-006 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-007 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-008 | AB1 | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020538-009 | AB1 | 1 | b8a1b40f171c… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Vivelle-Dot
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ESTRADIOL | .075 mg/d |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 4TI98Z838E | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 241946 | Internal RxNorm lookup |
| 242891 | Internal RxNorm lookup |
| 242892 | Internal RxNorm lookup |
| 248478 | Internal RxNorm lookup |
| 284378 | Internal RxNorm lookup |
| 310172 | Internal RxNorm lookup |
| 310176 | Internal RxNorm lookup |
| 310183 | Internal RxNorm lookup |
| 1149632 | Internal RxNorm lookup |
| 1149634 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 66758-148-40 | Vivelle-Dot | 8 in 1 BOX | PATCH, EXTENDED RELEASE | 8 | 17 | |
| 66758-148-40 | Vivelle-Dot | 3 in 1 CARTON | PATCH, EXTENDED RELEASE | 3 | 17 | |
| 66758-148-58 | Vivelle-Dot | 3.5 d in 1 PATCH | PATCH, EXTENDED RELEASE | 3.5 | 17 | |
| 66758-148-58 | Vivelle-Dot | 1 in 1 POUCH | PATCH, EXTENDED RELEASE | 1 | 17 | |
| 66758-148-83 | Vivelle-Dot | 8 in 1 BOX | PATCH, EXTENDED RELEASE | 8 | 17 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 66758-148-58 | EA - Each | 66758-148 | e7056fdb-a9e9-408d-8baa-fd540967dfb8 | 1 | 2024-08-12 |
| 66758-148-83 | EA - Each | 66758-148 | 45a1bd6c-1d24-4764-9484-83cf041f7646 | 1 | 2024-07-12 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vivelle-Dot | ESTRADIOL | Sandoz Inc | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 2023-11-17 | Boxed warning, Warnings, Adverse reactions | 020538 NDA020538 66758-148-83 66758-148 66758014883 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 248478 | estradiol 0.025 MG/Day Twice Weekly Transdermal System | PSN | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 241946 | estradiol 0.0375 MG/Day Twice Weekly Transdermal System | PSN | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 242891 | estradiol 0.05 MG/Day Twice Weekly Transdermal System | PSN | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 1149632 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | PSN | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 242892 | estradiol 0.1 MG/Day Twice Weekly Transdermal System | PSN | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 284378 | Vivelle dot 0.025 MG/Day Twice Weekly Transdermal System | PSN | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310172 | Vivelle dot 0.0375 MG/Day Twice Weekly Transdermal System | PSN | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310176 | Vivelle dot 0.05 MG/Day Twice Weekly Transdermal System | PSN | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 1149634 | Vivelle dot 0.075 MG/Day Twice Weekly Transdermal System | PSN | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310183 | Vivelle dot 0.1 MG/Day Twice Weekly Transdermal System | PSN | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 284378 | 84 HR estradiol 0.00104 MG/HR Transdermal System [Vivelle] | SBD | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310172 | 84 HR estradiol 0.00156 MG/HR Transdermal System [Vivelle] | SBD | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310176 | 84 HR estradiol 0.00208 MG/HR Transdermal System [Vivelle] | SBD | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 1149634 | 84 HR estradiol 0.00313 MG/HR Transdermal System [Vivelle] | SBD | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310183 | 84 HR estradiol 0.00417 MG/HR Transdermal System [Vivelle] | SBD | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 248478 | 84 HR estradiol 0.00104 MG/HR Transdermal System | SCD | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 241946 | 84 HR estradiol 0.00156 MG/HR Transdermal System | SCD | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 242891 | 84 HR estradiol 0.00208 MG/HR Transdermal System | SCD | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 1149632 | 84 HR estradiol 0.00313 MG/HR Transdermal System | SCD | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 242892 | 84 HR estradiol 0.00417 MG/HR Transdermal System | SCD | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 284378 | 84 HR Vivelle 0.00104 MG/HR Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310172 | 84 HR Vivelle 0.00156 MG/HR Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310176 | 84 HR Vivelle 0.00208 MG/HR Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 1149634 | 84 HR Vivelle 0.00313 MG/HR Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310183 | 84 HR Vivelle 0.00417 MG/HR Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 248478 | estradiol 0.00104 MG/HR 84 HR Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 241946 | estradiol 0.00156 MG/HR 84 HR Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 242891 | estradiol 0.00208 MG/HR 84 HR Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 1149632 | estradiol 0.00313 MG/HR 84 HR Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 242892 | estradiol 0.00417 MG/HR 84 HR Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 248478 | estradiol 0.025 MG/Day Twice Weekly Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 248478 | estradiol 0.025 MG/Day Twice Weekly Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 241946 | estradiol 0.0375 MG/Day Twice Weekly Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 242891 | estradiol 0.05 MG/Day Twice Weekly Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 1149632 | estradiol 0.075 MG/Day Twice Weekly Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 242892 | estradiol 0.1 MG/24HR Twice Weekly Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 242892 | estradiol 0.1 MG/Day Twice Weekly Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 241946 | estradiol 37.5 MCG/Day Twice Weekly Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 242891 | estradiol 50 MCG/Day Twice Weekly Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 1149632 | estradiol 75 MCG/Day Twice Weekly Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 284378 | Vivelle 0.025 MG/24HR Twice Weekly Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310183 | Vivelle 0.1 MG/24HR Twice Weekly Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 284378 | Vivelle dot 0.025 MG/Day Twice Weekly Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310172 | Vivelle dot 0.0375 MG/24HR Twice Weekly Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310172 | Vivelle dot 0.0375 MG/Day Twice Weekly Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310176 | Vivelle Dot 0.05 MG/24HR Twice Weekly Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310176 | Vivelle dot 0.05 MG/Day Twice Weekly Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 1149634 | Vivelle Dot 0.075 MG/24HR Twice Weekly Transdermal Patch | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 1149634 | Vivelle dot 0.075 MG/Day Twice Weekly Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
| 310183 | Vivelle dot 0.1 MG/Day Twice Weekly Transdermal System | SY | 5ccb77f9-d47b-4381-ad5c-5b92524e1c4a | 17 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 66758-148-83 | 66758014883 | 8 POUCH in 1 BOX (66758-148-83) / 1 PATCH in 1 POUCH (66758-148-58) / 3.5 d in 1 PATCH | 8 pouch | 2024-07-01 | No | No | Current |